FDA Inspection 1103024 — NATCO Pharma Limited Chemical Division Chennai
The FDA completed an inspection of NATCO Pharma Limited Chemical Division Chennai on July 12, 2019 in Chennai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chennai (India)